Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

E. Galvani; R. Alfieri; E. Giovannetti; A. Cavazzoni; S. La Monica; M. Galetti; C. Fumarola; M. Bonelli; M. Mor; M. Tiseo; G.J. Peters; P.G. Petronini; A. Ardizzoni

doi:https://doi.org/10.2174/138161213804547222

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

E. Galvani, R. Alfieri, E. Giovannetti, A. Cavazzoni, S. La Monica, M. Galetti, C. Fumarola, M. Bonelli, M. Mor, M. Tiseo, G.J. Peters, P.G. Petronini, A. Ardizzoni

Medical oncology laboratory (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

29 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	818-832
Journal	Current pharmaceutical design
Volume	19
Issue number	5
DOIs	https://doi.org/10.2174/138161213804547222
Publication status	Published - 2013

Access to Document

https://doi.org/10.2174/138161213804547222

Cite this

Galvani, E., Alfieri, R., Giovannetti, E., Cavazzoni, A., La Monica, S., Galetti, M., Fumarola, C., Bonelli, M., Mor, M., Tiseo, M., Peters, G. J., Petronini, P. G., & Ardizzoni, A. (2013). Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer. Current pharmaceutical design, 19(5), 818-832. https://doi.org/10.2174/138161213804547222

@article{be241ba1ba7d44bbbae790be9f5588ca,

title = "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer",

author = "E. Galvani and R. Alfieri and E. Giovannetti and A. Cavazzoni and {La Monica}, S. and M. Galetti and C. Fumarola and M. Bonelli and M. Mor and M. Tiseo and G.J. Peters and P.G. Petronini and A. Ardizzoni",

year = "2013",

doi = "https://doi.org/10.2174/138161213804547222",

language = "Undefined/Unknown",

volume = "19",

pages = "818--832",

journal = "Current pharmaceutical design",

issn = "1381-6128",

publisher = "Bentham Science Publishers B.V.",

number = "5",

}

Galvani, E, Alfieri, R, Giovannetti, E, Cavazzoni, A, La Monica, S, Galetti, M, Fumarola, C, Bonelli, M, Mor, M, Tiseo, M, Peters, GJ, Petronini, PG & Ardizzoni, A 2013, 'Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer', Current pharmaceutical design, vol. 19, no. 5, pp. 818-832. https://doi.org/10.2174/138161213804547222

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer. / Galvani, E.; Alfieri, R.; Giovannetti, E. et al.
In: Current pharmaceutical design, Vol. 19, No. 5, 2013, p. 818-832.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

AU - Galvani, E.

AU - Alfieri, R.

AU - Giovannetti, E.

AU - Cavazzoni, A.

AU - La Monica, S.

AU - Galetti, M.

AU - Fumarola, C.

AU - Bonelli, M.

AU - Mor, M.

AU - Tiseo, M.

AU - Peters, G.J.

AU - Petronini, P.G.

AU - Ardizzoni, A.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.2174/138161213804547222

DO - https://doi.org/10.2174/138161213804547222

M3 - Article

SN - 1381-6128

VL - 19

SP - 818

EP - 832

JO - Current pharmaceutical design

JF - Current pharmaceutical design

IS - 5

ER -

Galvani E, Alfieri R, Giovannetti E, Cavazzoni A, La Monica S, Galetti M et al. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer. Current pharmaceutical design. 2013;19(5):818-832. doi: https://doi.org/10.2174/138161213804547222